Cooper Companies | Actif À Court Terme



Current Assets Changement Date
Abbott USD 23.66B 146M 2024-12
Align Technology USD 2.49B 104.95M 2024-12
AtriCure USD 267.83M 1.46M 2024-12
Avanos Medical USD 393.4M 79.2M 2024-12
Bausch Health Companies USD 5.35B 140M 2024-09
Baxter International USD 8.85B 11M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Dentsply International USD 1.75B 175M 2024-12
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Globus Medical USD 2.18B 120.73M 2024-12
Haemonetics USD 1.01B 49.97M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.54B 4.33B 2024-12
J&J USD 55.89B 2.64B 2024-12
Medtronic USD 22.51B 75M 2025-01
Merit Medical Systems USD 923.77M 154.54M 2024-12
Novartis USD 29.7B 1.56B 2024-12
ResMed USD 2.84B 195.05M 2024-12
STAAR Surgical USD 367.94M 29.17M 2024-12
Steris USD 1.9B 40.02M 2024-12
Stryker USD 14.85B 174M 2024-12
Tandem Diabetes Care USD 724.49M 28.33M 2024-12
Teleflex USD 1.47B 28.18M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Cooper Companies Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.